| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.1 | 0.5 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |